Your saying CYP signing a phase 2 deal for agvhd in Japan is a huge deal but MSB talking with the Chinese FDA next month about p3/approval, with one of the worlds biggest pharma companies and $40mil already in the bag isnt more exciting?
MSB Price at posting:
$1.08 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)